Page 183 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 183

CHAPTER 10  Adrenoceptor Antagonist Drugs     169


                    activity may enhance skeletal muscle tremor, it is not surprising   and feet in winter. CNS effects include mild sedation, vivid dreams,
                    that β antagonists have been found to reduce certain tremors (see   and rarely, depression. Discontinuing the use of β blockers in any
                    Chapter 28). The somatic manifestations of anxiety may respond   patient who develops psychiatric depression should be seriously
                    dramatically to low doses of propranolol, particularly when taken   considered if clinically feasible. It has been claimed that β-receptor
                    prophylactically. For example, benefit has been found in musicians   antagonist drugs with low lipid solubility are associated with a lower
                    with  performance anxiety  (“stage fright”).  Propranolol  may   incidence of CNS adverse effects than compounds with higher lipid
                    contribute to the symptomatic treatment of alcohol withdrawal   solubility (Table 10–2). Further studies designed to compare the
                    in some patients.                                    CNS adverse effects of various drugs are required before specific
                                                                         recommendations can be made, although it seems reasonable to try
                    Miscellaneous                                        the hydrophilic drugs nadolol or atenolol in a patient who experi-
                                                                         ences unpleasant CNS effects with other β blockers.
                    Beta-receptor antagonists have been found to diminish portal
                    vein pressure in patients with cirrhosis. There is evidence that   The major adverse effects of β-receptor antagonist drugs relate
                    both propranolol and nadolol decrease the incidence of the first   to the predictable consequences of  β blockade. Beta -receptor
                                                                                                                   2
                    episode of bleeding from  esophageal varices and decrease the   blockade associated with the use of nonselective agents com-
                    mortality rate associated with bleeding in patients with cirrhosis.   monly causes worsening of preexisting asthma and other forms of
                    Nadolol in combination with isosorbide mononitrate appears to   airway obstruction without having these consequences in normal
                    be more efficacious than sclerotherapy in preventing rebleeding   individuals. Indeed, relatively trivial asthma may become severe
                    in patients who have previously bled from esophageal varices.   after β blockade. However, because of their lifesaving potential
                    Variceal band ligation in combination with a β antagonist may be   in cardiovascular disease, strong consideration should be given
                    more efficacious.                                    to individualized therapeutic trials in some classes of patients,
                       In the current era of repurposing established drugs that are well   eg, those with chronic obstructive pulmonary disease who have
                                                                                                              1
                    tolerated, unexpected benefits can emerge. Infantile hemangio-  appropriate indications for β blockers. While β -selective drugs
                    mas are the most common vascular tumors of infancy, which can   may have less effect on airways than nonselective β antagonists,
                    disfigure or impair vital functions. Propranolol at 2 mg/kg/d has   they must be used very cautiously in patients with reactive airway
                                                                                   1
                    been found to reduce the volume, color, and elevation of infantile   disease. Beta -selective antagonists are generally well tolerated in
                    hemangioma in infants younger than 6 months and children up   patients with mild to moderate  peripheral vascular  disease,  but
                    to 5 years of age, perhaps displacing more toxic drugs such as    caution is  required  in  patients  with  severe  peripheral  vascular
                    systemic glucocorticoids, vincristine, and interferon-alfa.  disease or vasospastic disorders.
                                                                           Beta-receptor blockade depresses myocardial contractility and
                                                                         excitability. In patients with abnormal myocardial function,
                    CHOICE OF A BETA-ADRENOCEPTOR                        cardiac output may be dependent on sympathetic drive. If this
                    ANTAGONIST DRUG                                      stimulus is removed by β blockade, cardiac decompensation may
                                                                         ensue. Thus, caution must be exercised in starting a β-receptor
                    Propranolol is the standard against which newer  β antagonists   antagonist in patients with compensated heart failure even though
                    for systemic use have been compared. In many years of very wide   long-term use of these drugs in these patients may prolong life.
                    use, propranolol has been found to be a safe and effective drug   A life-threatening adverse cardiac effect of a β antagonist may be
                    for many indications. Since it is possible that some actions of a   overcome directly with isoproterenol or with glucagon (glucagon
                    β-receptor antagonist may relate to some other effect of the drug,   stimulates the heart via glucagon receptors, which are not blocked
                    these drugs should not be considered interchangeable for all appli-  by β antagonists), but neither of these methods is without hazard.
                    cations. For example, only β antagonists known to be effective in   A very small dose of a β antagonist (eg, 10 mg of propranolol)
                    stable heart failure or in prophylactic therapy after myocardial   may provoke severe cardiac failure in a susceptible individual.
                    infarction should be used for those indications. It is possible that   Beta blockers may interact with the calcium antagonist vera-
                    the beneficial effects of one drug in these settings might not be   pamil; severe hypotension, bradycardia, heart failure, and cardiac
                    shared by another drug in the same class. The possible advantages   conduction abnormalities have all been described. These adverse
                    and disadvantages of  β-receptor partial agonists have not been   effects may even arise in susceptible patients taking a topical
                    clearly defined in clinical settings, although current evidence sug-  (ophthalmic) β blocker and oral verapamil.
                    gests that they are probably less efficacious in secondary preven-  Patients with ischemic heart disease or renovascular hyperten-
                    tion after a myocardial infarction compared with pure antagonists.  sion may be at increased risk if β blockade is suddenly interrupted.
                                                                         The mechanism of this effect might involve up-regulation of the
                                                                         number of β receptors. Until better evidence is available regard-
                    CLINICAL TOXICITY OF THE BETA-                       ing the magnitude of the risk, prudence dictates the gradual
                    RECEPTOR ANTAGONIST DRUGS                            tapering rather than abrupt cessation of dosage when these drugs
                                                                         are discontinued, especially drugs with short half-lives, such as
                    Many adverse effects have been reported for propranolol but most   propranolol and metoprolol.
                    are minor. Bradycardia is the most common adverse cardiac effect   The incidence of hypoglycemic episodes exacerbated by β-blocking
                    of  β-blocking drugs. Sometimes patients note coolness of hands   agents in diabetics is unknown. Nevertheless, it is inadvisable to use
   178   179   180   181   182   183   184   185   186   187   188